Home » Topics » BioWorld Science

BioWorld Science
RSS

Oscient updates status of leading programs

July 22, 2004

Conclusion of phase II study of Liprostin for PVD

July 22, 2004

Preliminary data suggest tipranavir is safe in heavily pretreated HIV-infected patients

July 22, 2004

Update on fosamprenavir in HIV infection

July 22, 2004

Results of first phase III multicenter study of naltrexone depot formulation

July 22, 2004

Transdermal lidocaine for the treatment of neuropathic sensory loss

July 21, 2004

Fujisawa discloses selective cyclooxygenase-1 inhibitors

July 21, 2004

ProSkelia claims vitronectin receptor antagonists

July 21, 2004

HIV integrase inhibitors described by Japan Tobacco

July 21, 2004

Yamanouchi reports VEGF inhibitors for angiogenesis-related disorders

July 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.